title: Letter: intravesical Bacille Calmette-Guerin (BCG) in immunologically compromised patients with bladder cancer--reply.
authors.affiliation: Department of Urology, Auckland City Hospital, Auckland, New Zealand.
authors.forename: Melanie
authors.initials: M
authors.lastname: Hwang
authors.forename: John
authors.initials: J
authors.lastname: Banerji
authors.forename: Mischel
authors.initials: M
authors.lastname: Neill
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D019737:Transplants / Q000706:statistics & numerical data*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine